# High fat diet-induced loss of pituitary plasticity in aging female mice with ablated leptin signaling in somatotropes

**Authors:** Tiffany K. Miles, Angela K. Odle, Stephanie D. Byrum, Alex N. Lagasse, Anessa C. Haney, Victoria G. Ortega, Ashley K. Herdman, Melanie C. MacNicol, Angus M. MacNicol, Gwen V. Childs

PMC · DOI: 10.3389/fendo.2025.1617109 · Frontiers in Endocrinology · 2025-07-16

## TL;DR

A high-fat diet reduces pituitary plasticity in aging female mice lacking leptin signaling in growth hormone-producing cells, leading to metabolic and hormonal changes.

## Contribution

This study reveals how a high-fat diet affects pituitary cell function and plasticity in aging mice with leptin signaling deficiency.

## Key findings

- High-fat diet reduced weight gain and improved glucose tolerance in mutant mice compared to controls.
- High-fat diet altered gene expression in multiple pituitary cell types, especially in older mutant mice.
- High-fat diet reversed progenitor cell marker and hormone transcript expression in mutant pituitary cells.

## Abstract

Somatotropes lacking leptin receptors (LEPR) produce less growth hormone and are poorly responsive to growth hormone releasing hormone (GHRH). Transcriptomic analysis reveals that the mutant somatotropes contain progenitor cell markers (Sox9+) and multiple pituitary hormone transcripts-(Pomc, Prl, Lhb, Tshb and Cga), suggesting that the cells are progenitor cells. The resulting GH deficiency contributes to adult-onset obesity in the mutant, due to an increase in abdominal fat.

This study examined how a high-fat diet (HFD) affected pituitary transcriptomic function in older (10-month) female mutants lacking leptin receptors (LEPR) in somatotropes and intact littermate controls. We hypothesized that pituitary cells from both the older control females and the female mutants would be greatly affected by the oxidative stress from the HFD.

Mice were exposed to a 60% HFD for 16 weeks, followed by glucose tolerance testing and 3-day monitoring in metabolic cages (CLAMS). Pituitaries were harvested, cells dispersed and subjected to single cell-RNA-seq (scRNA-seq) with bioinformatic analysis. Serum was collected and analyzed for pituitary hormones and cytokines.

The HFD resulted in elevated serum leptin and IL-6 in both mutants and controls, and reduced serum growth hormone (GH) and prolactin (PRL) levels. However, adrenocorticotropin (ACTH) levels were elevated in controls but not mutants. Unexpectedly, whereas controls gained as much weight as younger females, somatotrope LEPR-null mutants on a HFD gained only 75% of the weight of controls, were more glucose tolerant, consumed less food, were more active in the metabolic cages, and had lower serum levels of insulin. Analysis of scRNA-seq revealed that the HFD induced differentially expressed genes (DEGs) in more distinct pituitary cell populations of older mice compared to previously reported findings in younger control females, indicating greater vulnerability in the older pituitary population. This was especially true in the mutant pituitary population. Ingenuity Pathway Analysis indicated that the DEGs included targets of critical upstream regulators important for pituitary cell function and plasticity (CREB, Fox01, cAMP, STAT3, insulin, TRH, GnRH, and leptin signaling pathways), with most pathways predicted to be downregulated by the HFD. Unlike controls, HFD-fed mutant cell populations exhibited DEGs consistent with the downregulation of translational regulatory pathways. Notably, the HFD reversed the increased expression of progenitor cell markers (Sox9+) and multiple pituitary hormone transcripts seen in the mutant on a control diet. Similarly, the HFD also reversed the expression of multiple pituitary hormone transcripts and progenitor markers in lactotropes, thyrotropes, and corticotropes from mutants.

The findings supported our hypothesis that both aging and the mutation (loss of LEPR in somatotropes) would render these mice more sensitive to a HFD as more pituitary cell types were affected transcriptionally. Collectively, these findings indicate that HFD and/or obese state may compromise pituitary plasticity by down-regulating translational processes and reducing expression in cells that may have multipotential functions. The oxidative stress of a HFD may thus limit the expression of pituitary progenitor cells.

## Linked entities

- **Genes:** LEPR (leptin receptor) [NCBI Gene 3953], SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662], POMC (proopiomelanocortin) [NCBI Gene 5443], PRL (prolactin) [NCBI Gene 5617], LHB (luteinizing hormone subunit beta) [NCBI Gene 3972], TSHB (thyroid stimulating hormone subunit beta) [NCBI Gene 7252], CGA (glycoprotein hormones, alpha polypeptide) [NCBI Gene 1081], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385], LOC110490984 (forkhead box protein O1-A) [NCBI Gene 110490984], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774]
- **Proteins:** PROLACTIN (PROLACTIN protein), lepa (leptin a), IL6 (interleukin 6), PIN (insulin precursor), TRH (thyrotropin releasing hormone), GNRH1 (gonadotropin releasing hormone 1)
- **Chemicals:** glucose (PubChem CID 5793)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Ghrh (growth hormone releasing hormone) [NCBI Gene 14601] {aka GRF, Ghrf}, Lhb (luteinizing hormone beta) [NCBI Gene 16866] {aka Gm29035, LH, LH-B, LSH-B, LSH-beta}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, Chga (chromogranin A) [NCBI Gene 12652] {aka ChrA, cgA}, Trh (thyrotropin releasing hormone) [NCBI Gene 22044] {aka Pro-TRH, Trf}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Pomc (pro-opiomelanocortin-alpha) [NCBI Gene 18976] {aka ACTH, BE, Beta-LPH, Clip, Gamma-LPH, Npp}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Tshb (thyroid stimulating hormone, beta subunit) [NCBI Gene 22094], Gh (growth hormone) [NCBI Gene 14599] {aka Gh1, Ghb1}, Lepr (leptin receptor) [NCBI Gene 16847] {aka B219, LEP-R, LEPROT, Leprb, Modb1, OB-RGRP}, Prl (prolactin) [NCBI Gene 19109] {aka Gha1, Prl1a1}, Gnrh1 (gonadotropin releasing hormone 1) [NCBI Gene 14714] {aka Gnrh, Gnrh2, LHRH, Lhrh1, Lnrh, hpg}
- **Diseases:** GH deficiency (MESH:D004393), obese (MESH:D009765)
- **Chemicals:** fat (MESH:D005223), glucose (MESH:D005947), pituitary hormone (MESH:D010907), cAMP (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307167/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12307167/full.md

## References

89 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307167/full.md

---
Source: https://tomesphere.com/paper/PMC12307167